By Jim Tate – One of my favorite books is The Big Short by Michael Lewis. It was eventually made into a movie by the same name and gives a clear view of the housing bubble that burst 10 years ago and pushed the US economy into the Great Recession. What fascinates me was the ability of some to predict, and profit, from knowing when the collapse would occur.
Read More
By Dr. Pawan Jindal – There are generally two ways to participate in MIPS in 2017: as an Individual or as a Group. Beginning 2018, there will be a third option available to individuals and small groups called the “Virtual Group”. The definition of Virtual Group comes from the definition of ‘virtual’ and ‘group’.
By Jim Tate – Recently, when I googled “MIPS timeline” I got 174,000 results. There sure are lots of pretty charts and colorful graphs out there. Most of them will let you know when this will happen and when that will occur.
By Jim Tate – Several weeks ago I wrote a post entitled “MIPS and Medicare Part B Drugs – Waiting for the Other Shoe to Drop”. Late last week the other shoe hit the floor with the release of the Final Rule.
As proposed in the 2018 Quality Payment Program proposed rule, solo practitioners and groups can choose to participate in the Merit-based Incentive Payment System (MIPS) as a virtual group for the 2018 performance period.
By Brandy Dehaven – Previously, any eligible clinician without CEMRT could receive reweighting of the ACI performance category, but as of October 1, 2017, clinicians will have to prove that their reasons for not having CEMRT are good enough to receive a hardship exception.
CMS issued a final rule for the 2018 Physician Fee Schedule and final rule with comment period for the QPP.
By Jim Tate – “Everybody talks about the weather, but nobody does anything about it”. I’m pretty sure Mark Twain said that. We might as well say “Everybody talks about MIPS, but nobody does anything about it”. Well, hardly anybody.
By Anshu Jindal – Unlike most tales, where you can enjoy any version of your liking, the key facts in this tale have long-term implications for healthcare providers and organizations, both in terms of money and reputation.